China conditionally approves four self-developed COVID-19 vaccines: official
Xinhua |
Updated: 2021-02-26 20:09
Share
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- AI agent to improve international law services in Shanghai
- Intl Services Shanghai expands reach with launch of Italian-language website, multimedia platforms
- China opened more than 900 national wetland parks in over two decades
- Vice-chairman of securities regulator under investigation
- Jinan launches 'Glocal' plan to promote cultural heritage
- Shenzhou XIX astronauts arrive in Beijing
